UNI-MB - logo
UMNIK - logo
 

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources UM. For full access, REGISTER.

1
hits: 2
1.
  • Efficacy of the Janus kinas... Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
    Frémond, Marie-Louise, MD; Rodero, Mathieu Paul, PhD; Jeremiah, Nadia, PhD ... Journal of allergy and clinical immunology, 12/2016, Volume: 138, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    The patients, aged between 5 and 12 years, exhibited the phenotypic variability associated with TMEM173-activating mutations,2-4 with lung disease and systemic inflammation being the major features ...
Full text

PDF
2.
  • Physical health conditions ... Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) study
    Barlogis, Vincent, MD; Mahlaoui, Nizar, MD; Auquier, Pascal, MD, PhD ... Journal of allergy and clinical immunology, 04/2017, Volume: 139, Issue: 4
    Journal Article
    Peer reviewed
    Open access

    Background Most children with primary immunodeficiencies (PIDs) now reach adulthood. However, few studies have evaluated their health status and health-related quality of life (HRQoL). Objective To ...
Full text

PDF

Load filters